# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Dear Coeptis Therapeutics
Exclusive rights to universal CAR technology platform designed to target multiple antigens simultaneously, recently expanded to...